Dr. Atkinson on Novel Combinations in Melanoma

Source: OncLive, November 2017

Victoria Atkinson, MD, medical oncologist, Princess Alexandra Hospital, University of Queensland, discusses novel combinations for the treatment of patients with melanoma.
According to Atkinson, there are many novel ideas and combinations including talimogene laherparepvec (T-VEC; Imlygic) and injecting plasmas.
Additionally, the combination of LAG3 and PD-1 will have phase III results released early next year, explains Atkinson. Other combinations include IDO inhibitors with PD-1, which has potential to improve response and reduce toxicity.